BRZ News
Subscribe

Search

4 results for “weight-loss drug”

Mercado Livre Enters Brazil’s Prescription Drug Market, Targeting High-Growth GLP-1 Category
PROMarkets• Sep 25

Mercado Livre Enters Brazil’s Prescription Drug Market, Targeting High-Growth GLP-1 Category

Latin America's largest e-commerce platform has begun selling GLP-1 weight-loss drugs and antibiotics in Brazil, causing major pharmacy chain stocks to fall.

Lula Boosts Welfare, Promises Expensive Weight-Loss Drugs Weeks Before Brazil Election
Politics• Sep 19

Lula Boosts Welfare, Promises Expensive Weight-Loss Drugs Weeks Before Brazil Election

President Lula announced a 15.04% increase to the Bolsa Família benefit and the inclusion of Semaglutide in the public health system, just 17 days before the first-round election.

Lula Pledges Free GLP-1 Weight-Loss Drugs via Brazil’s Public Health System (SUS)
PROPolitics• Sep 18

Lula Pledges Free GLP-1 Weight-Loss Drugs via Brazil’s Public Health System (SUS)

President Lula announced that costly GLP-1 obesity treatments will be provided free of charge through Brazil’s Unified Health System (SUS) for severely obese patients.

Investing• Aug 21

Mounjaro Launch Fuels Surge in Brazilian Pharmacy Sales as GLP-1 Battle Intensifies

Eli Lilly's tirzepatide, Mounjaro, has become a high-margin sales driver for major Brazilian pharmacy chains like Raia Drogasil.